Dogwood Therapeutics, Inc. (DWTX) Form SCHEDULE 13D/A — Oct 27, 2026
On October 26, 2026, Sealbond Limited closed its previously announced private placement with Dogwood Therapeutics, purchasing 4,098,360 shares of common stock at $1.22 per share for approximately $5.0 million. Following the placement, CK Life Sciences Int'l., (Holdings) Inc. — the indirect parent of Sealbond and Conjoint Inc. — may be deemed to beneficially own 75.2% of Dogwood's outstanding shares, with Sealbond directly holding 67.8% and Conjoint holding 7.4%.
Key figures
- Gross Proceeds
- 5000000
- Offering Price
- 1.22
- Shares Offered
- 4098360
- Shares Outstanding
- 38227913
- Closing Date
- 2026-10-26
- Conjoint Shares
- 2842638
- Sealbond Shares
- 25920693
- Conjoint Percent
- 7.4%
- Sealbond Percent
- 67.8%
- Ck Life Sciences Percent
- 75.2%
AI analysis
Red flags3 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.